State Street Corp Aim Immuno Tech Inc. Transaction History
State Street Corp
- $2.21 Trillion
- Q1 2024
A detailed history of State Street Corp transactions in Aim Immuno Tech Inc. stock. As of the latest transaction made, State Street Corp holds 173,103 shares of AIM stock, worth $65,779. This represents 0.0% of its overall portfolio holdings.
Number of Shares
173,103
Previous 173,103
-0.0%
Holding current value
$65,779
Previous $76,000
6.58%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding AIM
# of Institutions
35Shares Held
4.09MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA1.99MShares$755,7070.0% of portfolio
-
Black Rock Inc. New York, NY698KShares$265,3660.0% of portfolio
-
Geode Capital Management, LLC Boston, MA352KShares$133,6290.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny221KShares$83,9070.0% of portfolio
-
Verition Fund Management LLC Greenwich, CT171KShares$64,9800.0% of portfolio
About AIM ImmunoTech Inc.
- Ticker AIM
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,049,300
- Market Cap $18.3M
- Description
- AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome...